GSK
804 hedge funds and large institutions have $12B invested in GSK in 2019 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 279 increasing their positions, 284 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
804
Holders Change
+1
Holders Change %
+0.12%
% of All Funds
17.66%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.31%
New
74
Increased
279
Reduced
284
Closed
68
Calls
$147M
Puts
$115M
Net Calls
+$31.8M
Net Calls Change
+$8.64M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$97.7M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$80.3M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$63.5M |
| 4 |
Fisher Asset Management
Camas,
Washington
|
+$60.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.5M |
